PT  - JOURNAL ARTICLE
AU  - Nikolaos P Daskalakis
AU  - Laura M Schultz
AU  - Elina Visoki
AU  - Tyler M Moore
AU  - Stirling T Argabright
AU  - Nathaniel G Harnett
AU  - Grace E DiDomenico
AU  - Varun Warrier
AU  - Laura Almasy
AU  - Ran Barzilay
TI  - Contributions of PTSD polygenic risk and environmental stress to suicidality in preadolescents
AID  - 10.1101/2021.05.30.21258082
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.30.21258082
4099  - http://medrxiv.org/content/early/2021/06/01/2021.05.30.21258082.short
4100  - http://medrxiv.org/content/early/2021/06/01/2021.05.30.21258082.full
AB  - Suicidal ideation and attempts (i.e., suicidality) are complex behaviors driven by environmental stress, genetic susceptibility, and their interaction. Preadolescent suicidality is a major health problem with rising rates, yet its underlying biology is understudied. Here we studied effects of genetic stress susceptibility, estimated by polygenic risk score (PRS) for post-traumatic-stress-disorder (PTSD), on preadolescent suicidality in participants from the Adolescent Brain Cognitive Development (ABCD) Study®. We further evaluated PTSD-PRS effects on suicidality in the presence of environmental stressors that are established suicide risk factors. Analyses included both European and African ancestry participants using PRS calculated based on summary statistics from ancestry-specific genome-wide association studies. In European ancestry participants (N=4,619, n=378 suicidal), PTSD-PRS was associated with preadolescent suicidality (odds ratio [OR]=1.12, 95%CI 1-1.25, p=0.038). Results in African ancestry participants (N=1,334, n=130 suicidal) showed a similar direction but were not statistically significant (OR=1.21, 95%CI 0.93-1.57, p=0.153). Sensitivity analyses using non-psychiatric polygenic score for height and using cross-ancestry PTSD-PRS did not reveal any association with suicidality, supporting the specificity of the association of ancestry-specific PTSD-PRS with suicidality. Environmental stressors were robustly associated with suicidality across ancestries with moderate effect size for negative life events and family conflict (OR 1.27-1.6); and with large effect size (OR ∼ 4) for sexual-orientation discrimination. When combined with environmental factors, PTSD-PRS showed marginal additive effects in explaining variability in suicidality, with no evidence for G X E interaction. Results support use of cross-phenotype PRS, specifically stress-susceptibility, as a robust genetic marker for suicidality risk early in the lifespan.Competing Interest StatementIn the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals and is on the scientific advisory board for Sentio Solutions for unrelated work. RB serves on the scientific board and reports stock ownership in Taliaz Health, with no conflict of interest relevant to this work. All other authors have no conflicts of interest to disclose.Funding StatementThis study was supported by the National Institute of Mental Health grants R21MH121909 (NPD), K23MH120437 (RB), R21MH123916 (RB), RO1MH117014 (TMM) and the Lifespan Brain Institute of Childrens Hospital of Philadelphia and Penn Medicine, University of Pennsylvania.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ABCD Study protocol was approved by the University of California, San Diego Institutional Review Board (IRB), and was exempted from a full review by the University of Pennsylvania IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the preparation of this article were obtained from the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). https://abcdstudy.org